Related Experiment Videos
[A novel function of tetrahydrobiopterin].
S Miwa1, Y Watanabe, K Koshimura
1Department of Pharmacology, Faculty of Medicine, Kyoto University, Japan.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|November 1, 1992
Summary
6R-L-erythro-5, 6, 7, 8-Tetrahydrobiopterin (6R-BH4) regulates neurotransmitter release via membrane receptors, independent of its cofactor role. This discovery offers potential therapeutic avenues for neuropsychiatric disorders.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- 6R-L-erythro-5, 6, 7, 8-Tetrahydrobiopterin (6R-BH4) is a known cofactor for hydroxylases and nitric oxide synthase.
- Recent findings reveal a novel, cofactor-independent function of 6R-BH4.
Purpose of the Study:
- To review experimental data on the novel functions of 6R-BH4.
- To explore the potential of 6R-BH4 in treating neuropsychiatric diseases.
Main Methods:
- Review of recent experimental data.
- Discussion of potential therapeutic applications.
Main Results:
- 6R-BH4 directly stimulates monoamine neurotransmitter release (dopamine, serotonin) via membrane receptors.
- 6R-BH4 indirectly stimulates non-monoamine neurotransmitter release (acetylcholine, glutamate) by activating monoaminergic systems.
Conclusions:
- 6R-BH4 acts as a regulator of neuronal function through novel mechanisms.
- 6R-BH4 shows promise for treating conditions like Parkinson's, Alzheimer's, depression, and autism.